KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) Equity Average (2016 - 2025)

Historic Equity Average for Staar Surgical (STAA) over the last 15 years, with Q3 2025 value amounting to $345.2 million.

  • Staar Surgical's Equity Average fell 1754.27% to $345.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $345.2 million, marking a year-over-year decrease of 1754.27%. This contributed to the annual value of $391.6 million for FY2024, which is 847.89% up from last year.
  • Latest data reveals that Staar Surgical reported Equity Average of $345.2 million as of Q3 2025, which was down 1754.27% from $343.3 million recorded in Q2 2025.
  • Over the past 5 years, Staar Surgical's Equity Average peaked at $418.6 million during Q3 2024, and registered a low of $191.8 million during Q1 2021.
  • Over the past 5 years, Staar Surgical's median Equity Average value was $340.4 million (recorded in 2023), while the average stood at $321.3 million.
  • Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 3397.27% in 2021, then plummeted by 1754.27% in 2025.
  • Quarter analysis of 5 years shows Staar Surgical's Equity Average stood at $253.8 million in 2021, then increased by 29.27% to $328.1 million in 2022, then grew by 16.5% to $382.3 million in 2023, then grew by 7.97% to $412.7 million in 2024, then decreased by 16.37% to $345.2 million in 2025.
  • Its last three reported values are $345.2 million in Q3 2025, $343.3 million for Q2 2025, and $373.7 million during Q1 2025.